Comments
Loading...
Repare Therapeutics Insider Trading Activity | NASDAQ:RPTX | Benzinga
Track the latest Repare Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Repare Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Repare Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 14, 2025, Maria Koehler, the company's EVP, CHIEF MEDICAL OFFICER sold 3.6K shares for $1.14 each.
- On March 14, 2025, Michael Zinda, the company's EVP, CHIEF SCIENTIFIC OFFICER sold 5.61K shares for $1.14 each.
- On March 14, 2025, Steve Forte, the company's EVP, CHIEF FINANCIAL OFFICER sold 6.88K shares for $1.14 each.
Ownership Statistics for Repare Therapeutics Inc
Shares Outstanding
42.511M
Insider Shares Owned
536.721K
Insider Percentage Owned
1.26%
Institutional Shares Held
3.614M
Institutional Percentage Held
8.50%
| Mar 14, 2025 | Maria Koehler | EVP, CHIEF MEDICAL OFFICER | -3.60K | $1.14 | -$4.10K | SELL | -1.55% | 227.81K | Mar 12 | View |
| Mar 14, 2025 | Michael Zinda | EVP, CHIEF SCIENTIFIC OFFICER | -5.61K | $1.14 | -$6.40K | SELL | -6.53% | 80.30K | Mar 12 | View |
| Mar 14, 2025 | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | -6.88K | $1.14 | -$7.85K | SELL | -11.16% | 54.79K | Mar 12 | View |
| Mar 14, 2025 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -21.18K | $1.14 | -$24.14K | SELL | -8.37% | 231.95K | Mar 12 | View |
| Apr 01, 2024 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -5.14K | $4.62 | -$23.78K | SELL | -2.39% | 210.24K | Mar 28 - Apr 01 | View |
| Apr 01, 2024 | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | -1.61K | $4.62 | -$7.45K | SELL | -3.48% | 44.77K | Mar 28 - Apr 01 | View |
| Apr 01, 2024 | Michael Zinda | EVP, CHIEF SCIENTIFIC OFFICER | -860.00 | $4.65 | -$4.00K | SELL | -1.18% | 71.91K | Mar 28 - Apr 01 | View |
| Apr 01, 2024 | Maria Koehler | EVP, CHIEF MEDICAL OFFICER | -800.00 | $4.65 | -$3.72K | SELL | -0.34% | 231.41K | Mar 28 - Apr 01 | View |
| Mar 27, 2024 | Steve Forte | EVP, CHIEF FINANCIAL OFFICER | -2.48K | $4.67 | -$11.56K | SELL | -5.54% | 42.21K | Mar 25 - Mar 27 | View |
| Mar 27, 2024 | Michael Zinda | EVP, CHIEF SCIENTIFIC OFFICER | -1.35K | $4.67 | -$6.30K | SELL | -1.82% | 72.77K | Mar 25 - Mar 27 | View |
| Mar 27, 2024 | Maria Koehler | EVP, CHIEF MEDICAL OFFICER | -1.50K | $4.67 | -$7.00K | SELL | -0.64% | 232.21K | Mar 25 - Mar 27 | View |
| Mar 27, 2024 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -7.95K | $4.69 | -$37.26K | SELL | -3.67% | 208.54K | Mar 25 - Mar 27 | View |
| Nov 17, 2023 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 1.23M | $5.09 | $6.25M | BUY | ∞ | 548.94K | Nov 15 - Nov 16 | View |
| Nov 03, 2023 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 783.71K | $3.60 | $2.82M | BUY | ∞ | 485.08K | Nov 02 | View |
| Jun 09, 2023 | Michael Zinda | EVP, CHIEF SCIENTIFIC OFFICER | -3.54K | $12.02 | -$42.55K | SELL | -5.55% | 60.12K | Jun 07 - Jun 08 | View |
| Jun 07, 2023 | Michael Zinda | EVP, CHIEF SCIENTIFIC OFFICER | -1.20K | $12.04 | -$14.45K | SELL | -1.70% | 69.39K | Jun 06 | View |
| Dec 13, 2022 | Jerel Davis | DIRECTOR | -250.00K | $16.00 | -$4.00M | SELL | -10.57% | 2.12M | Dec 09 | View |
| Jun 15, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 149.16K | $12.73 | $1.90M | BUY | 56.62% | 412.60K | Jun 13 | View |
| Jun 07, 2022 | Versant Vantage I LPVersant Vantage I GP LPVersant Vantage I GPGP LLC | 10% OWNER | -1.45M | $12.25 | -$9.19M | SELL | -86.25% | 231.21K | Jun 03 - Jun 06 | View |
| Jun 07, 2022 | Versant Ventures V LLCVersant Ophthalmic Affiliates I LPVersant Affiliates Fund V LPVersant Venture Capital V Canada LPVersant Ventures V GPGP Canada IncVersant Venture Capital V LPVersant Venture Capital VI LPVersant Ventures VI GP LPVersant Ventures VI GPGP LLCVersant Ventures V Canada LP | 10% OWNER | -1.45M | $12.25 | -$9.19M | SELL | -86.25% | 231.21K | Jun 03 - Jun 06 | View |
| Jun 07, 2022 | Jerel Davis | DIRECTOR | -1.44M | $12.25 | -$9.19M | SELL | -85.11% | 252.09K | Jun 03 - Jun 06 | View |
| Jun 06, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 1.84M | $11.90 | $21.86M | BUY | ∞ | 406.44K | Jun 02 - Jun 06 | View |
| May 20, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 420.00K | $8.50 | $3.57M | BUY | ∞ | 313.36K | May 18 | View |
| Mar 16, 2022 | Michael Zinda | EVP, CHIEF SCIENCE OFFICER | -533.00 | $11.30 | -$6.02K | SELL | -1.14% | 46.04K | Mar 15 | View |
| Jan 21, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 997.96K | $14.10 | $14.07M | BUY | ∞ | 307.63K | Jan 19 | View |
| Nov 18, 2021 | Thomas Civik | DIRECTOR | 7.50K | $28.08 | $210.60K | BUY | ∞ | 7.50K | Nov 16 | View |
| Nov 17, 2021 | Michael Zinda | EVP, CHIEF SCIENCE OFFICER | -20.00K | $27.33 | -$546.61K | SELL | -97.40% | 533.00 | Nov 15 | View |
| Sep 08, 2021 | David P Bonita | DIRECTOR | -8.08K | $33.99 | -$274.79K | SELL | -7.75% | 96.19K | Sep 03 - Sep 07 | View |
| Sep 08, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCORBIMED CAPITAL LLC | DIRECTOR | -8.08K | $33.99 | -$274.79K | SELL | -7.75% | 96.19K | Sep 03 - Sep 07 | View |
| Sep 02, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCORBIMED CAPITAL LLC | DIRECTOR | -37.86K | $34.08 | -$1.29M | SELL | -28.20% | 96.43K | Aug 31 - Sep 02 | View |
| Sep 02, 2021 | David P Bonita | DIRECTOR | -37.86K | $34.08 | -$1.29M | SELL | -28.20% | 96.43K | Aug 31 - Sep 02 | View |
| Aug 30, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCORBIMED CAPITAL LLC | DIRECTOR | -18.07K | $34.07 | -$615.75K | SELL | -15.63% | 97.54K | Aug 26 - Aug 30 | View |
| Aug 30, 2021 | David P Bonita | DIRECTOR | -18.07K | $34.07 | -$615.75K | SELL | -15.63% | 97.54K | Aug 26 - Aug 30 | View |
| Aug 25, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCORBIMED CAPITAL LLC | DIRECTOR | -18.21K | $34.17 | -$622.43K | SELL | -15.66% | 98.07K | Aug 23 - Aug 25 | View |
| Aug 25, 2021 | David P Bonita | DIRECTOR | -18.21K | $34.17 | -$622.43K | SELL | -15.66% | 98.07K | Aug 23 - Aug 25 | View |
| Aug 25, 2021 | David P Bonita | DIRECTOR | -20.33K | $34.10 | -$693.21K | SELL | -17.09% | 98.61K | Aug 17 - Aug 18 | View |
| Aug 20, 2021 | Michael Zinda | EVP, CHIEF SCIENCE OFFICER | -15.00K | $33.99 | -$509.89K | SELL | -42.21% | 20.53K | Aug 16 | View |
| Aug 19, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCORBIMED CAPITAL LLC | DIRECTOR | -20.33K | $34.10 | -$693.21K | SELL | -17.09% | 98.61K | Aug 17 - Aug 18 | View |
| Aug 19, 2021 | David P Bonita | DIRECTOR | -20.33K | $34.10 | -$693.21K | SELL | -17.09% | 98.61K | Aug 17 - Aug 18 | View |
| Jul 13, 2021 | Todd Foley | DIRECTOR | -27.35K | $33.55 | -$917.68K | SELL | -1.20% | 2.24M | Jul 09 - Jul 12 | View |
| Jul 13, 2021 | Ansbert Gadicke | 10% OWNER | -62.08K | $33.55 | -$2.08M | SELL | -1.57% | 3.88M | Jul 09 - Jul 12 | View |
| Jun 30, 2021 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -1.54K | $35.61 | -$54.91K | SELL | -1.53% | 99.47K | Jun 28 | View |
| Jun 30, 2021 | Todd Foley | DIRECTOR | -8.46K | $34.06 | -$288.14K | SELL | -0.37% | 2.27M | Jun 28 - Jun 29 | View |
| Jun 30, 2021 | Ansbert Gadicke | 10% OWNER | -19.20K | $34.06 | -$653.92K | SELL | -0.48% | 3.94M | Jun 28 - Jun 29 | View |
| Jun 28, 2021 | Todd Foley | DIRECTOR | -12.64K | $33.51 | -$423.62K | SELL | -0.55% | 2.28M | Jun 24 - Jun 25 | View |
| Jun 28, 2021 | Ansbert Gadicke | 10% OWNER | -28.69K | $33.51 | -$961.46K | SELL | -0.72% | 3.96M | Jun 24 - Jun 25 | View |
| Jun 23, 2021 | Todd Foley | DIRECTOR | -18.86K | $34.36 | -$647.95K | SELL | -0.82% | 2.29M | Jun 21 - Jun 23 | View |
| Jun 23, 2021 | Ansbert Gadicke | 10% OWNER | -42.80K | $34.36 | -$1.47M | SELL | -1.06% | 3.99M | Jun 21 - Jun 23 | View |
| Jun 21, 2021 | Todd Foley | DIRECTOR | -18.29K | $33.77 | -$617.76K | SELL | -0.79% | 2.31M | Jun 17 - Jun 18 | View |
| Jun 21, 2021 | Ansbert Gadicke | 10% OWNER | -41.52K | $33.77 | -$1.40M | SELL | -1.02% | 4.04M | Jun 17 - Jun 18 | View |
| Jun 16, 2021 | Todd Foley | DIRECTOR | -2.74K | $33.25 | -$91.21K | SELL | -0.12% | 2.33M | Jun 14 - Jun 16 | View |
| Jun 16, 2021 | Ansbert Gadicke | 10% OWNER | -6.23K | $33.25 | -$207.07K | SELL | -0.15% | 4.08M | Jun 14 - Jun 16 | View |
| Jun 10, 2021 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -1.58K | $35.00 | -$55.16K | SELL | -1.54% | 101.01K | Jun 09 | View |
| Jun 10, 2021 | Todd Foley | DIRECTOR | -27.07K | $34.05 | -$921.53K | SELL | -1.15% | 2.33M | Jun 08 - Jun 09 | View |
| Jun 10, 2021 | Ansbert Gadicke | 10% OWNER | -61.43K | $34.05 | -$2.09M | SELL | -1.48% | 4.08M | Jun 08 - Jun 09 | View |
| Jun 07, 2021 | Todd Foley | DIRECTOR | -25.62K | $32.01 | -$820.27K | SELL | -1.07% | 2.36M | Jun 03 - Jun 07 | View |
| Jun 07, 2021 | Ansbert Gadicke | 10% OWNER | -58.15K | $32.01 | -$1.86M | SELL | -1.38% | 4.14M | Jun 03 - Jun 07 | View |
| Jun 07, 2021 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -36.00K | $16.37 | -$1.27M | SELL | -87.80% | 5.00K | Jun 03 - Jun 04 | View |
| Jun 02, 2021 | Todd Foley | DIRECTOR | -16.79K | $32.47 | -$545.04K | SELL | -0.70% | 2.38M | May 28 - Jun 02 | View |
| Jun 02, 2021 | Ansbert Gadicke | 10% OWNER | -38.10K | $32.47 | -$1.24M | SELL | -0.90% | 4.20M | May 28 - Jun 02 | View |
| May 27, 2021 | Todd Foley | DIRECTOR | -16.99K | $32.82 | -$557.63K | SELL | -0.70% | 2.40M | May 25 - May 27 | View |
| May 27, 2021 | Ansbert Gadicke | 10% OWNER | -38.56K | $32.82 | -$1.27M | SELL | -0.90% | 4.24M | May 25 - May 27 | View |
| May 24, 2021 | Todd Foley | DIRECTOR | -143.14K | $34.75 | -$4.97M | SELL | -5.59% | 2.42M | May 21 - May 24 | View |
| May 24, 2021 | Ansbert Gadicke | 10% OWNER | -324.87K | $34.75 | -$11.29M | SELL | -7.06% | 4.28M | May 21 - May 24 | View |
| May 21, 2021 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -3.77K | $35.03 | -$132.07K | SELL | -2.65% | 138.58K | May 20 | View |
| May 20, 2021 | Ansbert Gadicke | 10% OWNER | -68.74K | $34.37 | -$1.61M | SELL | -1.47% | 4.60M | May 18 - May 20 | View |
| May 20, 2021 | Todd Foley | DIRECTOR | -42.50K | $34.37 | -$710.27K | SELL | -1.63% | 2.56M | May 18 - May 20 | View |
| May 20, 2021 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -5.60K | $35.04 | -$196.23K | SELL | -3.78% | 142.35K | May 18 - May 19 | View |
| May 18, 2021 | Michael Zinda | EVP, CHIEF SCIENCE OFFICER | -15.00K | $32.71 | -$490.71K | SELL | -29.68% | 35.53K | May 17 | View |
| Apr 19, 2021 | Mitchell Lloyd Segal | PRESIDENT AND CEO | -5.51K | $35.01 | -$192.98K | SELL | -3.59% | 147.95K | Apr 15 | View |
| Mar 15, 2021 | Todd Foley | DIRECTOR | -400.68K | $28.18 | -$10.61M | SELL | -13.34% | 2.60M | Mar 12 - Mar 15 | View |
| Mar 15, 2021 | Ansbert Gadicke | 10% OWNER | -670.73K | $28.18 | -$19.59M | SELL | -12.55% | 4.67M | Mar 12 - Mar 15 | View |
| Dec 30, 2020 | Michael Zinda | — | -34.70K | $17.99 | -$1.18M | OPTION EXERCISE | -40.71% | 50.53K | Dec 28 - Dec 29 | View |
| Dec 28, 2020 | Michael Zinda | — | 0.00 | $17.73 | -$1.82M | OPTION EXERCISE | 0.00% | 85.23K | Dec 22 - Dec 24 | View |
| Dec 22, 2020 | Michael Zinda | — | 0.00 | $17.75 | -$1.23M | OPTION EXERCISE | 0.00% | 85.23K | Dec 21 | View |
| Dec 18, 2020 | Michael Zinda | — | 0.00 | $18.39 | -$571.87K | OPTION EXERCISE | 0.00% | 85.23K | Dec 16 - Dec 18 | View |
| Jun 25, 2020 | Versant Vantage I LPVersant Vantage I GP LPVersant Vantage I GPGP LLC | — | 6.50M | $20.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 3.42M | Jun 23 | View |
| Jun 25, 2020 | Davis Jerel | — | 6.50M | $20.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 3.42M | Jun 23 | View |
| Jun 25, 2020 | Versant Ventures V LLCVersant Ophthalmic Affiliates I LPVersant Affiliates Fund V LPVersant Venture Capital V Canada LPVersant Ventures V GPGP Canada IncVersant Venture Capital V LPVersant Venture Capital VI LPVersant Ventures VI GP LPVersant Ventures VI GPGP LLCVersant Ventures V Canada LP | — | 6.50M | $20.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 3.42M | Jun 23 | View |
| Jun 25, 2020 | Mitchell Lloyd Segal | — | 5.00K | $20.00 | $100.00K | PURCHASE | 3.37% | 153.47K | Jun 23 | View |
| Jun 25, 2020 | Steve Forte | — | 5.00K | $20.00 | $100.00K | PURCHASE | ∞ | 5.00K | Jun 23 | View |
| Jun 25, 2020 | CAROL SCHAFER | — | 8.00K | $20.00 | $160.00K | PURCHASE | ∞ | 8.00K | Jun 23 | View |
| Jun 25, 2020 | Briggs Morrison | — | 4.80K | $20.00 | $96.00K | PURCHASE | ∞ | 4.80K | Jun 23 | View |
| Jun 25, 2020 | ANN RHOADS | — | 4.00K | $20.00 | $80.00K | PURCHASE | ∞ | 4.00K | Jun 23 | View |
| Jun 25, 2020 | David Bonita | — | 3.38M | $20.00 | $15.48M | DERIVATIVE CONVERSION | ∞ | 99.20K | Jun 23 | View |
| Jun 25, 2020 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCORBIMED CAPITAL LLC | — | 3.38M | $20.00 | $15.48M | DERIVATIVE CONVERSION | ∞ | 99.20K | Jun 23 | View |
| Jun 25, 2020 | Ansbert Gadicke | — | 5.39M | $20.00 | $10.00M | DERIVATIVE CONVERSION | ∞ | 5.39M | Jun 23 | View |
| Jun 25, 2020 | Todd Foley | — | 3.00M | $20.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 3.00M | Jun 23 | View |
| Jun 25, 2020 | MPM BioVentures LPMPM Asset Management Investors BV LLCMPM BioVentures B LPMPM BioVentures LLCMPM BioVentures GP LLCLUKE EVNIN | — | 3.00M | $20.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 3.00M | Jun 23 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.